Clinical Trials Logo

Shift-work Disorder clinical trials

View clinical trials related to Shift-work Disorder.

Filter by:

NCT ID: NCT04788953 Recruiting - Clinical trials for Excessive Sleepiness

Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder

Start date: July 21, 2021
Phase: Phase 4
Study type: Interventional

In this research study the investigators want to learn more about whether the medication Solriamfetol improves daytime sleepiness in workers who start work at very early times (between 3 and 6am).

NCT ID: NCT00950885 Completed - Shift-work Disorder Clinical Trials

Melatonin Treatment for Induced Transient Insomnia

Start date: September 2009
Phase: N/A
Study type: Interventional

Melatonin supplements have been reported to be an effective treatment for circadian rhythm sleep disorders, including shift work dyssomnia, jet-lag, delayed sleep phase syndrome, and sleep disruption suffered by many blind individuals. However, the mechanism(s) by which melatonin affects the timing of sleep are not well-understood. The purpose of this study is to determine if melatonin improves sleep and performance on a schedule simulating eastward travel. This study will provide information regarding the mechanism of action of melatonin that will be critical for the use of melatonin as a treatment for circadian rhythm sleep disorders.